Lucia Da Ros

Aviano, 33081, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Time-varying hazard rates reveal patterns of progression in HR+/HER2- metastatic breast cancer: Towards risk-adapted monitoring.

Time-varying hazard rates reveal patterns of progression in HR+/HER2- metastatic breast cancer: Towards risk-adapted monitoring.

Journal: Translational oncology

Published: July 06, 2026

Idiosyncratic Drug-Induced Liver Injury and Trastuzumab Deruxtecan in Breast Cancer: A Case Report.

Idiosyncratic Drug-Induced Liver Injury and Trastuzumab Deruxtecan in Breast Cancer: A Case Report.

Journal: Current oncology (Toronto, Ont.)

Published: September 01, 2025

Epigenetic and fragment-based profiling across CDK4/6 inhibitors in first-line HR+/HER2- metastatic breast cancer. An ancillary analysis of the MAGNETIC.1 study.

Epigenetic and fragment-based profiling across CDK4/6 inhibitors in first-line HR+/HER2- metastatic breast cancer. An ancillary analysis of the MAGNETIC.1 study.

Journal: Breast (Edinburgh, Scotland)

Published: June 24, 2025

Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?

Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?

Journal: Expert review of anticancer therapy

Published: June 10, 2024

Null Mismatch Repair Proteins Expression Reveals the Temporal Molecular Events in Lynch Syndrome-Related Cancers.

Null Mismatch Repair Proteins Expression Reveals the Temporal Molecular Events in Lynch Syndrome-Related Cancers.

Journal: Diagnostics (Basel, Switzerland)

Published: March 26, 2024

Effect of L. crispatus M247 Administration on Pregnancy Outcomes in Women Undergoing IVF: A Controlled, Retrospective, Observational, and Open-Label Study.

Effect of L. crispatus M247 Administration on Pregnancy Outcomes in Women Undergoing IVF: A Controlled, Retrospective, Observational, and Open-Label Study.

Journal: Microorganisms

Published: October 02, 2023

Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool.

Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool.

Journal: Genes

Published: March 26, 2023

Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group.

Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group.

Journal: Medical oncology (Northwood, London, England)

Published: March 19, 2021

First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study.

First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study.

Journal: Breast (Edinburgh, Scotland)

Published: November 17, 2020

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer.

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer.

Journal: Frontiers in oncology

Published: April 08, 2020

The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer.

The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer.

Journal: Journal of geriatric oncology

Published: January 14, 2020

Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside.

Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside.

Journal: Cancers

Published: May 14, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026